Regulatory Reactivity: FDA and the Response to COVID-19
Regulatory Reactivity: FDA and the Response to COVID-19
About this item
Full title
Regulatory Reactivity: FDA and the Response to COVID-19
Author / Creator
Publisher
Food and Drug Law Institute (FDLI)
Journal title
Food and drug law journal, 2021-01, Vol.76 (2), p.318-336
Language
English
Formats
Publication information
Publisher
Food and Drug Law Institute (FDLI)
Subjects
More information
Scope and Contents
Contents
The immense pressures created by the COVID-19 pandemic have exposed ingrained shortcomings in the regulatory and administrative apparatus for addressing public health crises, shortcomings that are particularly salient in the context of FDA’s emergency response. Political and public pressure, along with more subtle pressures exerted by private secto...
Alternative Titles
Full title
Regulatory Reactivity: FDA and the Response to COVID-19
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_jstor_primary_27091368
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_jstor_primary_27091368
Other Identifiers
ISSN
1064-590X
How to access this item
Log in as a Library member
